These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

528 related items for PubMed ID: 11859969

  • 1. Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression.
    Simon M, Park TW, Köster G, Mahlberg R, Hackenbroch M, Boström J, Löning T, Schramm J.
    J Neurooncol; 2001 Dec; 55(3):149-58. PubMed ID: 11859969
    [Abstract] [Full Text] [Related]

  • 2. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J, Meyer-Puttlitz B, Wolter M, Blaschke B, Weber RG, Lichter P, Ichimura K, Collins VP, Reifenberger G.
    Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
    [Abstract] [Full Text] [Related]

  • 3. Alternative splicing of the p15 cdk inhibitor in glioblastoma multiforme.
    Simon M, Köster G, Ludwig M, Mahlberg R, Rho S, Watzka M, Schramm J.
    Acta Neuropathol; 2001 Aug; 102(2):167-74. PubMed ID: 11563632
    [Abstract] [Full Text] [Related]

  • 4. Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas.
    Bisogna M, Calvano JE, Ho GH, Orlow I, Cordón-Cardó C, Borgen PI, Van Zee KJ.
    Cancer Genet Cytogenet; 2001 Mar; 125(2):131-8. PubMed ID: 11369056
    [Abstract] [Full Text] [Related]

  • 5. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
    Haviernik P, Schmidt M, Hu X, Wolff L.
    Oncogene; 2003 Mar 20; 22(11):1600-10. PubMed ID: 12642863
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors.
    Endo M, Kobayashi C, Setsu N, Takahashi Y, Kohashi K, Yamamoto H, Tamiya S, Matsuda S, Iwamoto Y, Tsuneyoshi M, Oda Y.
    Clin Cancer Res; 2011 Jun 01; 17(11):3771-82. PubMed ID: 21262917
    [Abstract] [Full Text] [Related]

  • 7. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
    Edmunds SC, Kelsell DP, Hungerford JL, Cree IA.
    Invest Ophthalmol Vis Sci; 2002 Sep 01; 43(9):2845-51. PubMed ID: 12202501
    [Abstract] [Full Text] [Related]

  • 8. p16 is a major inactivation target in hepatocellular carcinoma.
    Jin M, Piao Z, Kim NG, Park C, Shin EC, Park JH, Jung HJ, Kim CG, Kim H.
    Cancer; 2000 Jul 01; 89(1):60-8. PubMed ID: 10897001
    [Abstract] [Full Text] [Related]

  • 9. Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia.
    Pabst T, Peters UR, Tinguely M, Schwaller J, Tschan M, Aebi S, Vonlanthen S, Borisch B, Betticher DC, Zimmermann A, Tobler A, Fey MF.
    Leuk Lymphoma; 2000 May 01; 37(5-6):639-48. PubMed ID: 11042528
    [Abstract] [Full Text] [Related]

  • 10. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
    Watanabe T, Katayama Y, Yoshino A, Komine C, Yokoyama T.
    Clin Cancer Res; 2003 Oct 15; 9(13):4884-90. PubMed ID: 14581362
    [Abstract] [Full Text] [Related]

  • 11. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P, Zaravinos A, Zioga M, Stratigos A, Baritaki S, Soufla G, Zoras O, Spandidos DA.
    Cancer Lett; 2008 Jun 08; 264(1):145-61. PubMed ID: 18331779
    [Abstract] [Full Text] [Related]

  • 12. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma.
    Kanellou P, Zaravinos A, Zioga M, Spandidos DA.
    Br J Dermatol; 2009 Jun 08; 160(6):1215-21. PubMed ID: 19298278
    [Abstract] [Full Text] [Related]

  • 13. The p15(INK4b)/p16(INK4a)/RB1 pathway is frequently deregulated in human pituitary adenomas.
    Ogino A, Yoshino A, Katayama Y, Watanabe T, Ota T, Komine C, Yokoyama T, Fukushima T.
    J Neuropathol Exp Neurol; 2005 May 08; 64(5):398-403. PubMed ID: 15892297
    [Abstract] [Full Text] [Related]

  • 14. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma.
    Chinnasri P, Pairojkul C, Jearanaikoon P, Sripa B, Bhudhisawasdi V, Tantimavanich S, Limpaiboon T.
    Hum Pathol; 2009 Jun 08; 40(6):817-26. PubMed ID: 19200577
    [Abstract] [Full Text] [Related]

  • 15. One INK4 gene and no ARF at the Fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus.
    Gilley J, Fried M.
    Oncogene; 2001 Nov 01; 20(50):7447-52. PubMed ID: 11704876
    [Abstract] [Full Text] [Related]

  • 16. Evidence of a role for the INK4 family of cyclin-dependent kinase inhibitors in ovarian granulosa cell tumors.
    Arcellana-Panlilio MY, Egeler RM, Ujack E, Magliocco A, Stuart GC, Robbins SM, Coppes MJ.
    Genes Chromosomes Cancer; 2002 Oct 01; 35(2):176-81. PubMed ID: 12203782
    [Abstract] [Full Text] [Related]

  • 17. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
    Holdt LM, Sass K, Gäbel G, Bergert H, Thiery J, Teupser D.
    Atherosclerosis; 2011 Feb 01; 214(2):264-70. PubMed ID: 20637465
    [Abstract] [Full Text] [Related]

  • 18. Alterations of INK4A and INK4B genes in adult soft tissue sarcomas: effect on survival.
    Orlow I, Drobnjak M, Zhang ZF, Lewis J, Woodruff JM, Brennan MF, Cordon-Cardo C.
    J Natl Cancer Inst; 1999 Jan 06; 91(1):73-9. PubMed ID: 9890173
    [Abstract] [Full Text] [Related]

  • 19. Mouse p10, an alternative spliced form of p15INK4b, inhibits cell cycle progression and malignant transformation.
    Pérez de Castro I, Benet M, Jiménez M, Alzabin S, Malumbres M, Pellicer A.
    Cancer Res; 2005 Apr 15; 65(8):3249-56. PubMed ID: 15833857
    [Abstract] [Full Text] [Related]

  • 20. Inactivation of the p14(ARF), p15(INK4B) and p16(INK4A) genes is a frequent event in human oral squamous cell carcinomas.
    Shintani S, Nakahara Y, Mihara M, Ueyama Y, Matsumura T.
    Oral Oncol; 2001 Sep 15; 37(6):498-504. PubMed ID: 11435176
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.